Exact Mass: 583.2682222000001
Exact Mass Matches: 583.2682222000001
Found 104 metabolites which its exact mass value is equals to given mass value 583.2682222000001,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
tricoumaroyl spermidine
C34H37N3O6 (583.2682222000001)
Annotation level-3
Brigatinib
C29H39ClN7O2P (583.2591233999999)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
tricoumaroyl spermidine
C34H37N3O6 (583.2682222000001)
Tricoumaroyl spermidine belongs to coumaric acids and derivatives class of compounds. Those are aromatic compounds containing Aromatic compounds containing a cinnamic acid moiety (or a derivative thereof) hydroxylated at the C2 (ortho-), C3 (meta-), or C4 (para-) carbon atom of the benzene ring. Tricoumaroyl spermidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Tricoumaroyl spermidine can be found in a number of food items such as winter squash, red rice, common pea, and eggplant, which makes tricoumaroyl spermidine a potential biomarker for the consumption of these food products.
Tricoumaroyl spermidine (isomer of 2951)
C34H37N3O6 (583.2682222000001)
Annotation level-3
Tricoumaroyl spermidine (isomer of 2952)
C34H37N3O6 (583.2682222000001)
Annotation level-3
Asp Phe Phe Arg
Asp Phe Arg Phe
Asp Arg Phe Phe
Glu His Ile Trp
Glu His Leu Trp
Glu His Trp Ile
Glu His Trp Leu
Glu Ile His Trp
Glu Ile Trp His
Glu Leu His Trp
Glu Leu Trp His
Glu Trp His Ile
Glu Trp His Leu
Glu Trp Ile His
Glu Trp Leu His
Phe Asp Phe Arg
Phe Asp Arg Phe
Phe Phe Asp Arg
Phe Phe Arg Asp
Phe Met Met Arg
C25H41N7O5S2 (583.2610456000001)
Phe Met Arg Met
C25H41N7O5S2 (583.2610456000001)
Phe Arg Asp Phe
Phe Arg Phe Asp
Phe Arg Met Met
C25H41N7O5S2 (583.2610456000001)
His Glu Ile Trp
His Glu Leu Trp
His Glu Trp Ile
His Glu Trp Leu
His Ile Glu Trp
His Ile Trp Glu
His Leu Glu Trp
His Leu Trp Glu
His Trp Glu Ile
His Trp Glu Leu
His Trp Ile Glu
His Trp Leu Glu
Ile Glu His Trp
Ile Glu Trp His
Ile His Glu Trp
Ile His Trp Glu
Ile Trp Glu His
Ile Trp His Glu
Leu Glu His Trp
Leu Glu Trp His
Leu His Glu Trp
Leu His Trp Glu
Leu Trp Glu His
Leu Trp His Glu
Met Phe Met Arg
C25H41N7O5S2 (583.2610456000001)
Met Phe Arg Met
C25H41N7O5S2 (583.2610456000001)
Met Met Phe Arg
C25H41N7O5S2 (583.2610456000001)
Met Met Arg Phe
C25H41N7O5S2 (583.2610456000001)
Met Arg Phe Met
C25H41N7O5S2 (583.2610456000001)
Met Arg Met Phe
C25H41N7O5S2 (583.2610456000001)
Arg Asp Phe Phe
Arg Phe Asp Phe
Arg Phe Phe Asp
Arg Phe Met Met
C25H41N7O5S2 (583.2610456000001)
Arg Met Phe Met
C25H41N7O5S2 (583.2610456000001)
Arg Met Met Phe
C25H41N7O5S2 (583.2610456000001)
Trp Glu His Ile
Trp Glu His Leu
Trp Glu Ile His
Trp Glu Leu His
Trp His Glu Ile
Trp His Glu Leu
Trp His Ile Glu
Trp His Leu Glu
Trp Ile Glu His
Trp Ile His Glu
Trp Leu Glu His
Trp Leu His Glu
(5R,6R)-2,4-Bis-(4-hydroxy-3-methoxybenzyl)-1,5-dibenzyl-3-oxo-6-hydroxy-1,2,4-triazacycloheptane
C34H37N3O6 (583.2682222000001)
Brigatinib
C29H39ClN7O2P (583.2591233999999)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3,24-dioxo-22-thia-2,25-diazatricyclo[18.7.1.021,26]octacosa-1(28),6,8,10,16,20,26-heptaen-13-yl] (2R)-2-aminopropanoate
C31H41N3O6S (583.2715926000001)
N-[(2R,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
N-[(2R,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-ylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
C34H37N3O6 (583.2682222000001)
ouabain(1-)
An organic anion that is the conjugate base of ouabain resulting from the deprotonation of the furanone moiety; major species at pH 7.3.
(1r,2s,3s,5s,6r,8s,10e,12r,13s,14s,15s,16r,17s)-14-(acetyloxy)-17-benzyl-6,13,19-trihydroxy-6,8,14,15-tetramethyl-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate
(1r,2s,3s,5s,6r,8s,10e,12r,13s,14s,15s,16r,17s)-13-(acetyloxy)-17-benzyl-6,14,19-trihydroxy-6,8,14,15-tetramethyl-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate
(2e)-n-{3-[(2e)-n-(4-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}butyl)-3-(4-hydroxyphenyl)prop-2-enamido]propyl}-3-(4-hydroxyphenyl)prop-2-enimidic acid
C34H37N3O6 (583.2682222000001)
(1r,2s,3s,5s,6r,8s,10e,12r,13s,14r,15s,16r,17s)-13-(acetyloxy)-17-benzyl-6,14,19-trihydroxy-6,8,14,15-tetramethyl-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate
n-{3-[n-(4-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}butyl)-3-(4-hydroxyphenyl)prop-2-enamido]propyl}-3-(4-hydroxyphenyl)prop-2-enimidic acid
C34H37N3O6 (583.2682222000001)
(1r,2s,3r,4s,4as,8ar)-4-[(1s)-1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-3-hydroxy-3,4,8,8a-tetramethyl-2-[(2-methylpropanoyl)oxy]-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl pyridine-3-carboxylate
(2e)-n-[(1e)-7-[(3-aminopropyl)amino]-1-(4-hydroxyphenyl)-3-oxohept-1-en-4-yl]-3-(4-hydroxyphenyl)-n-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]prop-2-enamide
C34H37N3O6 (583.2682222000001)